Form 4: AIM ImmunoTech Director Nancy Bryan Acquires Shares
SEC Form 4 Filing
Director Nancy Bryan purchased 38,462 shares of AIM ImmunoTech Inc. at $0.39 per share on March 21, 2024.
Summary
- On March 21, 2024, Nancy Bryan, a director of AIM ImmunoTech Inc., acquired 38,462 shares of common stock.
- The purchase price was $0.39 per share.
- Following the transaction, Ms. Bryan directly owns 38,462 shares of AIM ImmunoTech Inc.
Sentiment
Score: 6
Explanation: Neutral sentiment. The document simply reports a transaction. A director buying shares is generally a positive sign, but without more context, it's difficult to assess the overall impact.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This transaction is a routine disclosure of insider trading activity. It provides transparency into the actions of company directors and their investment decisions.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/21/2024 | Date of transaction: Nancy Bryan acquired shares of AIM ImmunoTech Inc. |
Keywords
AIM ImmunoTech Inc., Nancy Bryan, Director, Share Acquisition, Form 4, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.